key: cord-0958458-0bj46u07
authors: Baik, Minyoul; Cha, Jihoon; Ahn, Sung Soo; Lee, Seung-Koo; Kim, Young Dae; Nam, Hyo Suk; Jeon, Soyoung; Lee, Hye Sun; Heo, Ji Hoe
title: Dual-Energy Computed Tomography Quantification of Extravasated Iodine and Hemorrhagic Transformation after Thrombectomy
date: 2022-01-31
journal: J Stroke
DOI: 10.5853/jos.2021.03391
sha: b584960cee56b33fb166e154851b13356f04217a
doc_id: 958458
cord_uid: 0bj46u07

nan

After endovascular thrombectomy (EVT) for ischemic stroke, early prediction of hemorrhagic transformation (HT) is important because HT often requires changes in therapeutic strategy. 1 Parenchymal hyperdense lesions, commonly observed on brain computed tomography scans after EVT, are caused by ischemic disruption of the blood-brain barrier and may be seen with secondary contrast staining or hemorrhage. [2] [3] [4] Dual-energy computed tomography (DECT) can accurately differentiate hemorrhage from contrast staining, and parenchymal contrast staining has been associated with the development of future HT. [2] [3] [4] However, whether the predictability may be improved when both imaging and clinical markers are simultaneously considered and the imaging marker associated with HT volume remain unclear.

Hence, we aimed to identify quantified markers for iodine extravasation on early DECT for the occurrence and volume of HT and investigate whether the simultaneous consideration of clinical markers could improve predictability.

This single-center retrospective study included patients with acute ischemic stroke with large artery occlusion of the anterior circulation, who underwent EVT and DECT within 60 minutes after EVT between May 2019 and October 2020 (Supplementary Figure 1 ). The details of the study design and imaging analysis are described in the Supplementary methods and Supplementary results. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Briefly, the volume of interest (VOI) was manually drawn by two independent readers. The VOIs covered all areas of increased iodine concentration within the corresponding infarct territory on the iodine map of DECT. Iodine concentrations were then extracted from the VOIs of all images, and quantitative parameters were calculated ( Figure 1 ). We determined the maximum iodine concentration and iodine extravasation volume that best predicted the occurrence and volume of HT, respectively (Supplementary Tables 1 and 2) . HT was diagnosed and measured for volume with T2*-weighted gradient echo (GRE) sequences 24 hours after EVT.

Of the 56 included patients, 28 (50.0%) had HT and nine (16.1%) had parenchymal hemorrhage (Supplementary Table  3 ). The mean HT volume on GRE was 6.3 mL (range, 0.0 to 89.6). After adjustment for clinical variables (Supplementary  Table 4 ), the maximum iodine concentration, defined as the iodine concentration at the 95th percentile, was the best predictor of HT occurrence (odds ratio, 8.29; 95% confidence interval, 2.30 to 29.93) ( Table 1) . Adding the clinical model, consisting of serum glucose level and collateral scores (Supplementary  Table 4 ), to the maximum iodine concentration improved the prediction of HT occurrence, as measured using the area under the receiver operating curve (0.834 to 0.931, P=0.044) (Supplementary Figure 2 ). The iodine extravasation volume, defined as the volume of iodine concentration >0.7 mg/mL, showed the best correlation with HT volume (β=0.44, R 2 =0.791, P<0.001, Table 1 ; Pearson's partial correlation coefficient r=0.823, P<0.001, Supplementary Figure 3) .

Herein, the maximum iodine concentration on DECT immediately after EVT was associated with HT occurrence. This find-ing is consistent with those of previous studies, where the maximum iodine concentration was determined in the manually defined hotspot ROI in the selected area. 3, 4 Using a VOIbased histogram approach, we could further reduce the potential risks of selection bias and determine the better imaging marker of iodine extravasation. 19 The clinical outcomes after an EVT may be directly associated with the HT volume or parenchymal hemorrhage rather than the presence of HT itself. 20 We found an independent linear correlation between the iodine extravasation volume on DECT and HT on GRE. Moreover, the prediction of HT improved when clinical variables were considered along with the imaging findings. Thus, it is necessary to consider both clinical factors and imaging markers when predicting HT. This study had some limitations. The sample size is small and most of the HTs in our study population had a small volume, which might limit its clinical impact.

In conclusion, the quantitative assessment of iodine extravasation on DECT immediately after EVT could help identify patients with a higher risk of HT development and a larger HT volume. Additionally, it would be beneficial to consider both clinical factors and imaging markers to predict HT. 

This study was approved by the local Institutional Review Board of Severance Hospital, Yonsei University Health System (IRB number: 4-2021-0268) with a waiver of informed consent due to the retrospective nature of this study. First, we determined which iodine markers, including maximum iodine concentration and volume of iodine concentration, better predicted hemorrhagic transformation (HT) occurrence and volume (Supplementary Tables 1 and 2 ). We performed multivariable regression analysis with these iodine markers, adjusting for clinical variables, to determine correlations with HT occurrence and volume. We further investigated whether the addition of clinical variables to iodine markers could improve HT prediction.

All patients underwent non-contrast computed tomography (CT), CT angiography, and CT perfusion (Revolution EVO, GE Healthcare, Milwaukee, WI, USA) at the emergency department on arrival. Patients were treated with intravenous alteplase (0.9 mg/kg) and/or endovascular thrombectomy (EVT) primarily based on current guidelines and recent trials. [5] [6] [7] Omnipaque (iohexol, GE Healthcare) and Visipaque (iodixanol, GE Healthcare) were used for CT angiography and catheter angiography, respectively. The devices for EVT included the following stent retrievers: Solitaire AB/FR (ev3, Irvine, CA, USA), Trevo Proview (Stryker, Fremont, CA, USA), Embotrap II (Neuravi, Galway, Ireland), and Aperio (Acandis, Pforzheim, Germany); and aspiration catheters, Penumbra ACE (Penumbra, Alameda, CA, USA), AXS Catalyst 6 (Stryker), and Sofia (Microvention, Tustin, CA, USA). Intra-arterial tirofiban, a glycoprotein IIb/IIIa antagonist, was used as an adjuvant therapy in cases of re-occlusion. Dual-energy computed tomography (DECT) was performed immediately after the EVT. Brain magnetic resonance imaging and magnetic resonance angiography were performed 24 hours after EVT.

The patients underwent DECT (SOMATOM Force, Siemens Healthineers, Erlangen, Germany) immediately after EVT. To minimize the time factor that affects the quantification of iodine markers, 8, 9 we included only patients with DECT within 60 minutes after EVT in accordance with previous studies. 3, 4 Non-contrast CT was performed in a dual-energy acquisition with two X-ray tubes operated at 80 kV and Sn150 kV, where "Sn" denotes the use of an additional tin filter that increases the mean photon energy of the respective spectrum. Scan parameters were as follows: collimation width, 192×0.6 mm; rotation time, 1.0 second; pitch, 0.7. The effective mA values were set to 450 mA at 80 kV and 300 mA at Sn150 kV. The volume CT dose index were 44.76 mGy.

During the study period, DECT data were unavailable at midnight. In addition, since the coronavirus disease 2019 (COVID-19) outbreak, patients with a body temperature of ≥37.3°C, or those with any symptoms associated with COVID-19, were not allowed to move from the angiographic suite or emergency department to other areas, including the CT room for DECT, until the result of reverse transcription polymerase chain reaction test for COVID-19 was reported. As such, DECT could not be performed within 60 minutes in several patients.

For each patient, simulated 120-kV images, virtual non-contrast images, and iodine map images were generated using a commercially available software (syngo.via, Dual-Energy CT Brain Hemorrhage application, version VA30A, Siemens Healthineers). For quantitative image analysis, the volume of interest (VOI) was manually drawn and placed in all areas with increased concentrations on the iodine map corresponding to the infarction area. The analysis was performed using a 3D slicer (https://www.slicer.org) by two independent readers (M.B. and J.C.). 10 If there was no visible area with increased iodine concentration, the ipsilateral basal ganglia were selected as the VOI. The iodine concentration within the VOIs of all the images was extracted. Quantitative parameters were calculated as follows using python 3.7 (Python Software Foundation, https:// www.python.org/): volumes of iodine concentration with >0.4, >0.7, >1.0, >1.3, >1.6, and >1.9 mg/mL; iodine concentrations of 95th, 99th, and 99.5th percentile VOIs; and mean iodine concentration of 0.1 and 1 mL with the highest iodine concentration ( Figure 1 ). The maximum iodine concentration, volume of iodine extravasation, and volume of HT showed excellent reliability between the two readers (intraclass correlation coefficients of 0.92, 0.97, and 0.93, respectively; all >0.90). The mean values recorded by the two readers were used for the statistical analysis.

Clinical and laboratory data were obtained from the Yonsei Stroke Registry. 11 Stroke subtypes, based on the Trial of ORG 10172 in the Acute Stroke Treatment classification, 12 were determined at the weekly stroke conference with a consensus among stroke neurologists. The subtypes were entered into the https://doi.org/10.5853/jos.2021.03391 registry. 11 The Alberta Stroke Program Early CT Score (ASPECTS) and collateral scores proposed by Tan et al. 13 were assessed on initial non-contrast CT and CT angiography. 14 HT was determined by the presence of any dark signal on gradient echo (GRE) images (conventional GRE sequence with 5 mm thickness) in the parenchyma of the corresponding infarction territory on diffusion-weighted imaging. To determine HT volume, VOIs were placed in all areas with a dark signal on the GRE image in the corresponding infarction territory. Parenchymal hemorrhage was defined in accordance with the European Cooperative Acute Stroke Study II framework. 15

Statistical analyses were performed using R version 4.0.3 (http://www.R-project.org). Univariable analyses were performed using an independent t-test or Mann-Whitney U test for continuous variables and a chi-square test for categorical variables, as appropriate. Multivariable analysis was conducted while adjusting for significant variables (P<0.05) in the univariable analyses (Supplementary Table 4 ). The area under curves (AUCs) were compared to find which iodine marker best predicted the HT occurrence. 16 Determinants for HT occurrence were studied using univariable logistic regression analyses. AUCs were calculated to determine whether the addition of the clinical variables to DECT variables could improve HT prediction. 17 We examined the correlation between the iodine markers and the HT volume using correlation coefficients and compared them using the Steigers Z-test. We calculated the univariable linear regression β coefficients, standard errors, R 2 , and P-values to identify variables related to HT volume. Multivariable linear regression analysis was used to determine the independent correlates of the HT volume. To assess the association between HT volume and iodine markers, Pearson's partial correlation analyses were performed between HT volume and maximum iodine concentration or the volume of iodine extravasation. Statistical significance was set at P<0.05.

We compared the predictability of the occurrence of HT between the VOI-based histogram method (maximum iodine concentration on DECT) and the conventional method (metallic hyperdensity sign on non-contrast brain CT). 16 The metallic hyperdensity sign was defined as a non-petechial intracerebral hyperdense lesion (diameter, ≥1 cm) in the basal ganglia and a maximum density of >90 hounsfield unit (HU) on simulated 120-kV images of DECT. 18 Maximum iodine concentration better predicted the occurrence of future HT than the conventional metallic hyperdensity sign (AUCs 0.834 vs. 0.732, P=0.044). The correlation coefficient between the volume of iodine concentration >0.7 mg/mL and the hemorrhagic transformation volume was higher than that of other iodine volume parameters. Hence, voxels with an iodine concentration >0.7 mg/mL were used to determine the volume of iodine extravasation. CI, confidence interval. Among the clinical variables, the serum glucose level at admission and collateral scores were associated with the occurrence of hemorrhagic transformation (HT) in univariable logistic regression analyses. The maximum iodine concentration was associated with HT occurrence, whereas the volume of iodine extravasation was not. In the univariable linear regression analyses, HT volume was associated with diabetes, prothrombin time, NIHSS score, ASPECTS score, maximum iodine concentration, and volume of iodine extravasation. OR, odds ratio; CI, confidence interval; SE, standard error; SBP, systolic blood pressure; PT, prothrombin time; INR, international normalized ratio; aPTT, activated partial thromboplastin time; eGFR, estimated glomerular filtration rate; NIHSS, National Institutes of Health Stroke Scale; ASPECTS, Alberta Stroke Program Early CT Score; TOAST, Trial of ORG 10172 in acute stroke treatment; CE, cardioembolism; IV, intravenous; tPA, tissue plasminogen activator; IA, intra-arterial; TICI, thrombolysis in cerebral infarction; DECT, dual-energy computed tomography; MRI, magnetic resonance imaging. 

Care of the post-thrombectomy patient

Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study

Iodine extravasation quantification on dual-energy CT of the brain performed after mechanical thrombectomy for acute ischemic stroke can predict hemorrhagic complications

Prediction of hemorrhage after successful recanalization in patients with acute ischemic stroke: improved risk stratification using dual-energy CT parenchymal iodine concentration ratio relative to the superior sagittal sinus

Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct

Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging

Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist

Dual energy CT after stroke thrombectomy alters assessment of hemorrhagic complications

3D slicer as an image computing platform for the Quantitative Imaging Network

Analysis of 1,000 patients with acute cerebral infarctions

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy

Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Metallic hyperdensity sign on noncontrast CT immediately after mechanical thrombectomy predicts parenchymal hemorrhage in patients with acute large-artery occlusion